Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity
Gesquière, J.C.; Dhaisne, J.M.; Marcinal-Lefebvre, A.; Bar, D.; Vincent, A.; Dupuis, B.
Annales Pharmaceutiques Francaises 40(3): 251-257
1982
ISSN/ISBN: 0003-4509 PMID: 6129826 Document Number: 196330
Document emailed within 1 workday
Related Documents
Conde, S.; Corral, C.; Lissavetzky; Darias, V.; Martin, D. 1986: Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol Il Farmaco; Edizione Scientifica 41(1): 80-88Mesnard, P. 1970: Various syntheses of therapeutic interest in the coumarin and chromone series Il Farmaco; Edizione Scientifica 25(1): 57-83
Balsamo, A.; Lapucci, A.; Macchia, B.; Macchia, M.; Orlandini, E.; Rossello, A.; Ferni, G.; Pinza, M. 1995: Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines Farmaco 50(4): 239-243
Wu, K.; Tong, Z.S.; Dai, C.S.; Li, L.; Zheng, S.X. 1993: Synthesis and bio-activity of coumarin derivatives and studies on its relationships between activity and lipophilicity Yao Xue Xue Bao 28(4): 266-272
Manna, F.; Bolasco, A.; Bizzarri, B.; Lena, R.; Chimenti, F.; Filippelli, A.; Palla, A.; Fontana, M. 1996: Synthesis and beta-adrenoreceptor blocking activity of [[3-(alkylamine)-2-hydroxypropyl]oximino]pyridines and O[3-(alkylamine)-2-hydroxypropyl]methylpyridine ketone oximes derivatives Farmaco 51(8-9): 579-587
Huang, X.L.; Xu, S.P.; Fu, Z.D.; An, B. 1996: Studies of chemopreventive agents against neoplasma: synthesis of 3-acetyl coumarin derivatives and relationship between antimutagenic activity and structure Yao Xue Xue Bao 31(6): 431-436
Rostan, A. 1978: Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms Schweizerische Rundschau für Medizin Praxis 67(1): 27-35
Khouili, M.; Guillaumet, G.; Coudert, G.; Pujol, M.D. 1996: Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II) Farmaco 51(3): 185-188
El-Kousy, S.M.; el-Torgoman, A.M.; el-Basiouny, A.A.; Hashem, A.I. 1988: Synthesis and reactions of some delta beta,gamma-butenolides with a study of their biological activity Die Pharmazie 43(2): 80-81
Mattioli, G.; Ricci, S.; Menozzi, A.; Teglio, V. 1982: Hemodynamic changes caused by beta-blocking agents with and without intrinsic sympathicomimetic activity and with and without cardioselective activity. Comparison of hypertensives at fixed and variable frequencies Minerva Cardioangiologica 30(3): 81-88
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Leonetti, G.; Sampieri, L.; Cuspidi, C.; Terzoli, L.; Rupoli, L.; Fruscio, M.; Gradnik, R.; Zanchetti, A. 1985: Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents? Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 3(3): S243-S245
Abiko, T.; Sekino, H. 1987: The synthesis of peptides with potential thymic hormone activity: the synthesis of endo-Arg38a-deacetylthymosin beta 10 Biotechnology and Applied Biochemistry 9(1): 20-30
Chan, P.S.; Ellenbogen, L. 1974: New evidence for the beta-adrenergic receptor blocking activity of dihydroergotamine Archives Internationales de Pharmacodynamie et de Therapie 209(2): 204-213
Lotti, B.; Fabrizi, G.; Vezzosi, O. 1971: Determination of 2-methyl-5-(pyridyl-3-acryloyloxy)-8-(beta-diethylminoethoxy)-furo-(2',3';6,7)-chromone hydrochloride Bollettino Chimico Farmaceutico 110(3): 151-160
Cavalleri, B.; Bellasio, E. 1970: Fluorinated organic compounds with potential biological activity. 8. Synthesis of beta-fluoro-beta-arylethylamine-N-derivatives Il Farmaco; Edizione Scientifica 25(12): 901-911
Shibasaki, K.; Uchida, W.; Shirai, Y.; Inagaki, O.; Asano, M.; Takenaka, T. 1994: Pharmacological properties of YM-15430-1, a 1,4-dihydropyridine derivative with beta 1-adrenoceptor-blocking activity Archives Internationales de Pharmacodynamie et de Therapie 328(2): 213-224
Ziegler, M.G.; Wilner, K.D. 1996: Sertraline does not alter the beta-adrenergic blocking activity of atenolol in healthy male volunteers Journal of Clinical Psychiatry 57(Suppl): 12-15
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594